Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
9CqWM2VpE1R9dW8S
Listen
